TAVOLETTI, GIANLUCA
TAVOLETTI, GIANLUCA
Universita' degli Studi di MILANO
Dual Biologic Therapy With Dupilumab and Risankizumab for Coexistent Prurigo Nodularis and Psoriasis
2026 D. Termini, G. Tavoletti, G. Avallone, A. Chiei Gallo, F.L. Boggio, M. Zussino, A.V. Marzano, S.M. Ferrucci
Phenotypic Switch From Atopic Dermatitis to Psoriasis During Dupilumab Therapy: A Real-Life Experience From a Tertiary Referral Center
2026 A. Chiei Gallo, G. Tavoletti, D. Termini, G. Avallone, F. Barei, P. Calzari, R. Pinto, A.V. Marzano, S.M. Ferrucci
Pan-JAK Inhibition Across Chronic Hand Eczema and Other Cutaneous Diseases: An Updated Review on Topical Delgocitinib
2026 D. Termini, G. Avallone, G. Tavoletti, J. Beaziz, C. Moltrasio, V. Boero, A.V. Marzano, S.M. Ferrucci
Tinea barbae following ruxolitinib cream application in a vitiligo patient: a case report
2026 M. Romagnuolo, L.C. Rossi, G. Tavoletti, F. Germiniasi, A. Grancini, C. Moltrasio, A.V. Marzano, S. Alberti-Violetti
Real-Life Perception of Treatment Effectiveness After 24 Weeks of Topical Ruxolitinib in Non-Segmental Vitiligo: Insights From Patient-Reported Outcomes
2026 S. Alberti-Violetti, G. Tavoletti, F. Del Signore, L.C. Rossi, M. Romagnuolo, N. Capurro, E. Cozzani, A.V. Marzano
Clinical outcomes of chlormethine gel in mycosis fungoides affecting “sensitive” areas: A retrospective case series
2025 G. Tavoletti, G. Avallone, P. Vezzoli, P. Sena, A.V. Marzano, E. Berti, S. Alberti‐violetti
Scabies: An updated review from epidemiology to current controversies and future perspectives
2025 G. Tavoletti, G. Avallone, A. Sechi, E. Cinotti, S. Veraldi, G. Micali, F. Lacarrubba, A.V. Marzano, G. Nazzaro
Pyoderma gangrenosum: pathogenetic mechanisms and their implications for treatment
2025 C. Moltrasio, M. Romagnuolo, G. Tavoletti, C.A. Maronese, A.V. Marzano
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis
2025 G. Avallone, A. Bombelli, L. Valtellini, G. Tavoletti, B. Galli, M. Rossi, M. Maurelli, G. Girolomoni, L. Gargiulo, A. Narcisi, F. Di Vico, M. Napolitano, L. Lazzeri, L. Calabrese, S. Caccavale, A. Balato, F. Barei, P. Calzari, C. Foti, I. Trave, E. Cozzani, F. Rongioletti, S. Lenti, C. Gurioli, E. Nettis, F. Caroppo, E. Errichetti, L. Bonzano, N. Gori, K. Peris, S. Lembo, L. Del Regno, M. Esposito, M.C. Fargnoli, P. Savoia, E. Esposto, R. Giuffrida, F. Guarneri, C. Patruno, E. Pezzolo, L. Stingeni, K. Hansel, L. Mastorino, M. Ortoncelli, S. Ribero, A.V. Marzano, S.M. Ferrucci
Massive asymptomatic infestation of Pthirus pubis
2025 G. Tavoletti, A.V. Marzano, G. Nazzaro
Severe Allergic Contact Dermatitis to Hair Dye in a Patient With Atopic Dermatitis During Dupilumab Therapy
2025 A. Chiei Gallo, G. Tavoletti, G. Avallone, E. Bono, F. Barei, P. Calzari, A.V. Marzano, S.M. Ferrucci
Trichoscopy of Terra Firma-Forme Dermatosis of the Scalp: A Case Report
2025 G. Tavoletti, L.B. Masferrer, M. Barbareschi, A.V. Marzano, A. Sechi
Tralokinumab-induced psoriasis relapse in a patient with atopic dermatitis
2025 A. Chiei Gallo, G. Tavoletti, D. Termini, A.V. Marzano, S.M. Ferrucci
Effectiveness and safety of combined dupilumab and risankizumab in concomitant atopic dermatitis and psoriasis
2025 D. Termini, G. Tavoletti, A. Chiei-Gallo, G. Avallone, F.L. Boggio, A.V. Marzano, S.M. Ferrucci
Effectiveness of dupilumab in tralokinumab-resistant patients with atopic dermatitis: A real-world experience from two referral centres
2025 G. Tavoletti, A. Chiei-Gallo, L. Gargiulo, G. Avallone, L. Ibba, F. Barei, P. Calzari, A. Narcisi, A.V. Marzano, S.M. Ferrucci
Effectiveness of Tralokinumab for Moderate-to-Severe Atopic Dermatitis Involving the Head-and-Neck Area: A Multicenter Retrospective Cohort Study
2025 G. Avallone, L. Valtellini, G. Tavoletti, L. Mastorino, M. Maurelli, E.V. Di Brizzi, E. Ippoliti, F. Barei, D. Termini, P. Quaglino, M. Ortoncelli, G. Girolomoni, A. Balato, N. Gori, K. Peris, A.V. Marzano, S.M. Ferrucci, S. Ribero
Melanoma Skin Cancer: A Comprehensive Review of Current Knowledge
2025 C. Caraviello, G. Nazzaro, G. Tavoletti, F. Boggio, N. Denaro, G. Murgia, E. Passoni, V. Benzecry Mancin, A.V. Marzano
Paediatric cutaneous lymphomas including rare subtypes: A 40‐year experience at a tertiary referral centre
2025 S. Alberti‐violetti, G. Avallone, C. Colonna, G. Tavoletti, L. Venegoni, V. Merlo, S. Cambiaghi, A.V. Marzano, E. Berti, R. Cavalli
Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review
2024 G. Avallone, G. Roccuzzo, A. Pileri, C. Agostinelli, C.A. Maronese, C. Aquino, G. Tavoletti, F. Onida, P. Fava, S. Ribero, A.V. Marzano, E. Berti, P. Quaglino, S. Alberti‐violetti
Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata
2024 G. Tavoletti, A. Chiei-Gallo, F. Barei, A.V. Marzano, S.M. Ferrucci